Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)
South Korea
· Delayed Price · Currency is KRW 15,820
-780 (-4.70%)
Nov 15, 2024, 9:00 AM KST
Hyundai Bioscience Revenue
Hyundai Bioscience had revenue of 1.09B KRW in the quarter ending June 30, 2024, a decrease of -66.07%. This brings the company's revenue in the last twelve months to 9.24B, down -11.84% year-over-year. In the year 2023, Hyundai Bioscience had annual revenue of 9.48B with 20.76% growth.
Revenue (ttm)
9.24B
Revenue Growth
-11.84%
P/S Ratio
68.30
Revenue / Employee
146.66M
Employees
63
Market Cap
629.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9.48B | 1.63B | 20.76% |
| Dec 31, 2022 | 7.85B | -1.39B | -15.04% |
| Dec 31, 2021 | 9.24B | -3.27B | -26.14% |
| Dec 31, 2020 | 12.51B | -17.57B | -58.41% |
| Dec 31, 2019 | 30.09B | -1.15B | -3.68% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition